HESI RN
HESI Pharmacology Questions
Extract:
Question 1 of 5
The nurse assesses a client with intermittent claudication who is receiving pentoxifylline. Which assessment should the nurse perform to determine the effectiveness of the medication?
Correct Answer: D
Rationale: Pentoxifylline improves blood flow in intermittent claudication. Monitoring pain scale (
D) assesses reduced leg pain during activity. Consciousness (
A), bowel sounds (
B), and urine output (
C) are unrelated.
Question 2 of 5
The home health nurse observes a client self-administering an epinephrine injection using an auto-injector pen. Which client action requires intervention by the nurse?
Correct Answer: C
Rationale: Epinephrine auto-injectors are single-use; cleaning for re-use (
C) risks infection or malfunction. Thigh administration (
A) is correct. Injecting through clothing (
B) may reduce efficacy but is less critical.
Choice D is a duplicate and addressed by C.
Question 3 of 5
A client with hepatic encephalopathy is receiving lactulose. Which assessment provides the nurse with the nest information to evaluate the client’s therapeutic response to the drug?
Correct Answer: B
Rationale: Lactulose reduces ammonia absorption in hepatic encephalopathy. Serum electrolytes and ammonia levels (
B) assess therapeutic response. Glucose (
A), stool (
C), and hepatic enzymes (
D) are less direct.
Question 4 of 5
Prior to administering the evening dose of carbamazepine, the nurse noted that the client’s morning carbamazepine level was 8.4 mg/L. Which action should the nurse take?
Correct Answer: D
Rationale: A carbamazepine level of 8.4 mg/L is therapeutic (4-12 mg/L). Administering the dose (
D) is appropriate. Withholding (
A), notifying (
B), or assessing side effects (
C) are unnecessary.
Question 5 of 5
A client with benign prostatic receives a new prescription of tamsulosin. Which intervention should the nurse use to monitor an adverse reaction?
Correct Answer: C
Rationale: Tamsulosin, an alpha-blocker, risks hypotension, causing dizziness or fainting. Monitoring blood pressure (
C) detects this adverse effect. Urine output (
A), bladder scans (
B), and weights (
D) are unrelated.